Abstract Percutaneous transcatheter mitral valvuloplasty is the indicated treatment of choice for symptomatic native mitral valve stenosis, but there have been limited reports of successful procedures of balloon valvuloplasty for bioprosthetic mitral valve stenosis. We present the case of a 62-year-old woman suffering from progressive dyspnea due to bioprosthetic mitral valve stenosis. The measured mean pressure gradient across the mitral valve was 30 mmHg and the mitral valve area was 0.73 cm 2 . Redoing mitral replacement was considered high risk and was refused by the patient. Percutaneous balloon valvuloplasty was performed with an Inoue balloon catheter inflated to 20 mm. The patient's symptoms immediately improved after the procedure, with no procedure-related complications. The mean pressure gradient across the valve decreased to 19 mmHg, and the mitral valve area increased to 1.21 cm 2 in postprocedural echocardiography. We conducted a literature search and identified 26 cases of balloon valvuloplasty for degenerated bioprosthetic valves. Of these, 14 cases were bioprosthetic mitral valves, and the results were favorable. However, more case reports are required to establish an evidence base for future expert recommendation of balloon valvuloplasty of prosthetic mitral valve. Meanwhile, balloon valvuloplasty will serve a niche role in highly selected patients with prosthetic mitral valve stenosis.
Introduction
Percutaneous transcatheter balloon valvuloplasty is a technique introduced in 1982 by Inoue et al. [1] , which eventually became the procedure of choice for most cases of native mitral valve stenosis [2] . However, balloon valvuloplasty for a degenerated bioprosthetic mitral valve is rarely performed. We report a successful case of balloon valvuloplasty in a patient with a prosthetic mitral valve stenosis, and review the related literature.
Case report
A 62-year-old woman with progressive dyspnea in New York Heart Association functional class III was referred to our hospital for treatment of bioprosthetic mitral valve stenosis. Transthoracic and transesophageal echocardiography revealed severe bioprosthetic mitral stenosis with elevated pulmonary artery systolic pressure of 85 mmHg. The measured mean pressure gradient across the mitral valve was 30 mmHg, and the mitral valve area calculated by pressure half-time was 0.73 cm 2 (Fig. 1a) . There was no thrombus and trivial mitral regurgitation on the echocardiography.
The patient had a history of coronary artery bypass graft surgery, with a left internal mammary artery graft to the left anterior descending artery and two saphenous vein grafts to the distal right coronary and second marginal coronary arterial segments dating from 9 years previously. Subsequently, the patient had undergone mitral valve replacement with a 23-mm Carpentier-Edwards bioprosthesis for mitral regurgitation, and aortic valve replacement with a 19-mm Carpentier-Edwards bioprosthesis for aortic stenosis 4 years previously. She suffered a gangrenous right foot that required amputation 1 month previously, and the wound healing was delayed. Just after the amputation, the patient developed congestive heart failure due to severe bioprosthetic mitral valve stenosis that was resistant to medical treatment. Redo mitral valve replacement was required, but the Society of Thoracic surgeons score predicted a 32.0 % risk of death for redo surgery. The patient rejected open surgery and consented to percutaneous balloon valvuloplasty.
Right heart catheterization showed that the pulmonary capillary wedge pressure was 39 mmHg, with a mean pulmonary artery pressure of 55 mmHg. Balloon valvuloplasty was performed as previously described with sequential inflations from 17 to 20 mm with a 20-mm Inoue balloon (Fig. 2) . After the balloon valvuloplasty, the pulmonary capillary wedge pressure decreased to 29 mmHg and the mean pulmonary artery pressure decreased to 41 mmHg. Cardiac index increased from 1.5 to 2.0 l/min/m 2 . The hemodynamic findings immediately before and after valvuloplasty are shown in Table 1 . Transthoracic echocardiography, performed 2 days later, showed that the mean pressure gradient across the mitral valve was reduced to 19 mmHg, and the mitral valve area increased to 1.21 cm 2 with trivial mitral regurgitation (Fig. 1b) . The patient's symptoms improved and exercise capacity increased immediately. There was no complication associated with the procedure. The patient was discharged from hospital 5 days after the procedure.
Discussion
Percutaneous transcatheter balloon valvuloplasty was first performed in 1982 by Kanji Inoue, who is the chief operator of the present case and also the author of the present report [1] . Following proof of its clinical efficacy in several reports, percutaneous mitral valvuloplasty has now become the indicated treatment in criteria-suitable cases of native mitral valve stenosis [2] . Balloon valvuloplasty for other valves including aortic, tricuspid, and pulmonary valves have also been performed in well-selected patients, with favorable outcomes [3] . In particular, with the advent of transcatheter aortic valve replacement, balloon aortic valvuloplasty is currently being applied more frequently [4, 5] . However, reports regarding balloon valvuloplasty for bioprosthetic valve failure in adult patients are extremely limited. A literature search identified 26 cases of balloon valvuloplasty for degenerated bioprosthetic valve: 14 cases in mitral position [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] , 6 cases in aortic position [16] [17] [18] [19] [20] , 4 cases in tricuspid position [21] [22] [23] [24] , and 2 cases in pulmonary position (Table 2) [16, 25] . The valvuloplasty for degenerative bioprosthesis in aortic position showed poorer outcomes; two patients died after the procedure and two required surgical valve replacement [16, 17, 19] . Valvuloplasty for bioprosthetic valve stenosis in other positions showed more favorable outcomes. After balloon valvuloplasty, symptoms of almost all patients improved. After balloon valvuloplasty for a prosthetic mitral valve, one patient developed a moderate mitral regurgitation at 6-month follow-up and a cusp rupture at 12 months [16] . Although no major procedure-related complications were reported with the exception of this patient, several authors have warned against performing valvuloplasty of a bioprosthetic mitral valve [26] . The dysfunction or obstruction of a prosthetic valve usually results from pannus ingrowth, leaflet calcification, thrombosis, or vegetation. In vitro studies suggest that the increased mitral valve area attained from balloon valvuloplasty results from balloon-induced leaflet tearing, calcium fractures, and cusp perforation [27] . We cannot draw any concrete conclusions from these limited experiences. More case reports are needed to establish an evidence base for future expert recommendation of balloon valvuloplasty of prosthetic mitral valves.
Recently, the transcatheter valve-in-valve technique is emerging as a therapeutic option for patients with failure of a previously implanted bioprosthetic valve [28, 29] . After receiving the favorable results for bioprosthetic aortic valve, the valve-in-valve technique for bioprosthetic mitral valve has been applied using the transapical approach, and is expected to become a complementary approach to redo mitral valve replacement. Although the valve-in-valve technique seems hopeful, the Ministry of Health, Labor and Welfare has not yet approved this procedure for mitral valve replacement in Japan. When compared with the valve-in-valve technique, the main advantage of balloon valvuloplasty is the less invasive percutaneous approach, omitting the need for apical incision and general anesthesia.
In conclusion, the present report demonstrates the successful use of percutaneous transcatheter balloon valvuloplasty for bioprosthetic mitral valve stenosis. Balloon valvuloplasty for a prosthetic mitral valve shows favorable outcomes in limited case reports. However, there are other opinions that warn against performing valvuloplasty for prosthetic mitral valves because the balloon valvuloplasty 
